Literature DB >> 8345960

Retinopathy of prematurity.

D L Phelps1.   

Abstract

Retinopathy of prematurity (ROP) remains a nonpreventable disorder associated with extreme prematurity. Recent advances in establishing the International Classification of ROP have facilitated both clinical care and research, highlighted by the demonstration of the effectiveness of cryoablative therapy for vision-threatening ROP. For those individuals who have ROP, early and life-long ophthalmic follow-up is critical. This is true for those with any residual retinal scars that we now know can lead to later vision loss as well as those who require services for the visually impaired.

Entities:  

Mesh:

Year:  1993        PMID: 8345960     DOI: 10.1016/s0031-3955(16)38581-9

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  4 in total

1.  Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity.

Authors:  M R Niesman; K A Johnson; J S Penn
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  A new system to record reliable pulse oximetry data from the Nellcor N-200 and its applications in studies of variability in infant oxygenation.

Authors:  D Sprague; M S Richardson; J W Baish; J S Kemp
Journal:  J Clin Monit       Date:  1996-01

3.  Oxygen therapy in pediatrics.

Authors:  S Deopujari
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

4.  Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study.

Authors:  Medardo Avila-Vazquez; Roque Maffrand; Mirta Sosa; Maria Franco; Beatriz Vaca De Alvarez; Maria Luisa Cafferata; Eduardo Bergel
Journal:  BMC Pediatr       Date:  2004-08-07       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.